Fig. 1From: Upregulation of miR-1825 inhibits the progression of glioblastoma by suppressing CDK14 though Wnt/β-catenin signaling pathwayThe association of miR-1825 differential expression with overall survival in GBM. a Decreased expression of miR-1825 in GBM tissue samples (n = 55). b Higher expression of miR-1825 in GBM patients exhibited a higher survival rate of GBM patients. **P < 0.01Back to article page